SCHEMBL659235

SCHEMBL659235

CCCCNC(=O)C1=CN(CC(=O)Nc2ccccc2)C=CC1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.45
TSHR P16473 1/20 0.45
EPHX1 P07099 3/20 0.43
ALDH1A1 P00352 2/20 0.43
HPGD P15428 3/20 0.41
GAA P10253 1/20 0.40
BCL2 P10415 1/20 0.40
MCL1 Q07820 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
CYP2C9 P11712 1/20 0.40
NAAA Q02083 1/20 0.40
MAPT P10636 1/20 0.39
PPARG P37231 2/20 0.39
ALOX15 P16050 2/20 0.39
LMNA P02545 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ICMT O60725 1/20 0.38
ALB P02768 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL660292 0.88 ALDH1A1 (0.43) HTTALDH1A1CYP2C9LMNAMEN1
SCHEMBL659989 0.82 MEN1 (0.44) TSHRALDH1A1HPGDL3MBTL1MAPT
SCHEMBL287827 0.81 ALDH1A1 (0.41) HTTALDH1A1GAACYP2C9LMNA
SCHEMBL27576643 0.76 EPHX1 (0.43) HTTTSHREPHX1ALDH1A1HPGD
SCHEMBL287496 0.75 KAT6A (0.44) HTTALDH1A1GAAMAPTMEN1
SCHEMBL286819 0.74 MAPT (0.43) HTTALDH1A1GAAMAPTLMNA
SCHEMBL27871714 0.72 ALDH1A1 (0.45) TSHRALDH1A1HPGDCYP2C9MAPT
SCHEMBL658736 0.72 NPSR1 (0.46) HTTALDH1A1HPGDGAACYP2C9
SCHEMBL27871697 0.70 L3MBTL1 (0.41) HTTALDH1A1L3MBTL1MAPTLMNA
SCHEMBL658611 0.69 CA12 (0.32) ALDH1A1MAPTLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS AGER, REN, AGT HTT 75/4885TSHR 4816/4885EPHX1 509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.